AsymmetRx Sues Rivals Over Cancer Diagnostic Test

Law360, New York (June 28, 2007, 12:00 AM EDT) -- Drug development and medical device company AsymmetRx Inc. filed suit against a group of rival diagnostic companies Wednesday, claiming they are infringing two of its patents describing certain antibodies used to diagnose prostate cancer.

In its complaint, filed in the U.S. District Court for the District of Massachusetts, AsymmetRx alleges that Biocare Medical LLC, EMD Biosciences Inc., Lab Vision Corp., Sigma Chemical Co. and Santa Cruz Biotechnology Inc. have all infringed on two patents it holds through the sale of products in the diagnostic and therapeutic...
To view the full article, register now.